Contribution of the cytosol and mitochondrial pathways to phosphoenolpyruvate formation during gluconeogenesis.
D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D002250:Carbon Radioisotopes; D002642:Chick Embryo; D003600:Cytosol / Q000201:enzymology / Q000378:metabolism*; D005943:Gluconeogenesis / Q000187:drug effects; D006168:Guinea Pigs; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D008314:Malonates / Q000378:metabolism; D008862:Microsomes, Liver / Q000201:enzymology; D008930:Mitochondria, Liver / Q000201:enzymology / Q000378:metabolism*; D010728:Phosphoenolpyruvate / Q000096:biosynthesis*; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D013045:Species Specificity; D014364:Tryptophan / Q000494:pharmacology
D002250:Carbon Radioisotopes; D008314:Malonates; D011725:Pyridines; D001224:Aspartic Acid; D010728:Phosphoenolpyruvate; D014364:Tryptophan; D010729:Phosphoenolpyruvate Carboxykinase (GTP)